Business Insider

Lilly's Emgality™ (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults

INDIANAPOLIS, Sept. 27, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality™ (galcanezumab-gnlm) 120 mg ...
Nasdaq

FDA Approves Emgality® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks

INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality ® (galcanezumab-gnlm) injection (300 ...
Healio

FDA grants headache drug priority review

Please provide your email address to receive an email when new articles are posted on . The FDA recently granted priority review to the supplemental Biologics License Application for Emgality ...
MarketWatch

Eli Lilly says FDA has approved new migraine drug Emgality

Eli Lilly and Company [s:lly] said late Thursday that the U.S. Food and Drug Administration has approved its drug Emgality for the preventive treatment of migraine in adults. Emgality is delivered via ...

Migraine prevention drug Emgality put on the Pharmaceutical Benefits Scheme, now hundreds of dollars cheaper

From June 1, the migraine prevention drug Emgality has been expanded on the Pharmaceutical Benefits Scheme, making it ...
MarketWatch

Eli Lilly's Emgality gets FDA approval for episodic cluster headaches

Eli Lilly & Co. said Wednesday Emgality injection was approved by the U.S. Food and Drug Administration for the treatment of episodic cluster headache in adults. Lilly said Emgality is the first and ...
CBS News

'This Is A Huge Deal': Researcher On New Migraine Drug

MINNEAPOLIS (CBSLocal) -- It is being called a breakthrough for migraine sufferers. A new FDA approved treatment called Emgality is the third in a class of new drugs that aim to stop the headaches ...
Healio

FDA approves Emgality for migraine prevention

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Emgality, a once-monthly, self-administered, subcutaneous injection, for the preventive ...
KRQE Blogs

First-Of-Its-Kind Head-to-Head Clinical Trial Reaffirms the Efficacy of Emgality in Episodic Migraine Prevention

The CHALLENGE-MIG study demonstrates Lilly's commitment to migraine research and results underscore that people living with episodic migraine deserve broad access to effective treatments "These ...
Nasdaq

Lilly's Emgality Gets FDA Priority Review for Cluster Headache

Eli Lilly and CompanyLLY announced that the FDA has granted a priority review to the supplemental biologics license application (sBLA) for its calcitonin gene-related peptide (CGRP) antibody, Emgality ...
OverSixty

Migraine prevention drug added to the PBS

Thousands of Australians living with frequent migraines will now be able to access a treatment many describe as life-changing ...